151 related articles for article (PubMed ID: 32316253)
1. The Lipopeptide MALP-2 Promotes Collateral Growth.
Troidl K; Schubert C; Vlacil AK; Chennupati R; Koch S; Schütt J; Oberoi R; Schaper W; Schmitz-Rixen T; Schieffer B; Grote K
Cells; 2020 Apr; 9(4):. PubMed ID: 32316253
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration.
Grote K; Schuett H; Salguero G; Grothusen C; Jagielska J; Drexler H; Mühlradt PF; Schieffer B
Blood; 2010 Mar; 115(12):2543-52. PubMed ID: 20056792
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury.
Grote K; Sonnenschein K; Kapopara PR; Hillmer A; Grothusen C; Salguero G; Kotlarz D; Schuett H; Bavendiek U; Schieffer B
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2097-104. PubMed ID: 23868938
[TBL] [Abstract][Full Text] [Related]
4. NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells.
Schuett J; Schuett H; Oberoi R; Koch AK; Pretzer S; Luchtefeld M; Schieffer B; Grote K
FASEB J; 2017 Jun; 31(6):2612-2624. PubMed ID: 28274989
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Amplified Arteriogenesis in Collateral Artery Segments Exposed to Reversed Flow Direction.
Heuslein JL; Meisner JK; Li X; Song J; Vincentelli H; Leiphart RJ; Ames EG; Blackman BR; Blackman BR; Price RJ
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2354-65. PubMed ID: 26338297
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-Phosphate Receptor 1 Activation Enhances Leptomeningeal Collateral Development and Improves Outcome after Stroke in Mice.
Iwasawa E; Ishibashi S; Suzuki M; Li F; Ichijo M; Miki K; Yokota T
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1237-1251. PubMed ID: 29337049
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 2/6-dependent stimulation of mesenchymal stem cells promotes angiogenesis by paracrine factors.
Grote K; Petri M; Liu C; Jehn P; Spalthoff S; Kokemüller H; Luchtefeld M; Tschernig T; Krettek C; Haasper C; Jagodzinski M
Eur Cell Mater; 2013 Sep; 26():66-79; discussion 79. PubMed ID: 24027020
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.
Schill T; Schön MP; Pletz N; Emmert S; Schön M
Exp Dermatol; 2012 Feb; 21(2):91-8. PubMed ID: 22044500
[TBL] [Abstract][Full Text] [Related]
9. Exercise promotes collateral artery growth mediated by monocytic nitric oxide.
Schirmer SH; Millenaar DN; Werner C; Schuh L; Degen A; Bettink SI; Lipp P; van Rooijen N; Meyer T; Böhm M; Laufs U
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1862-71. PubMed ID: 26088573
[TBL] [Abstract][Full Text] [Related]
10. Endothelial nitric oxide synthase activity is essential for vasodilation during blood flow recovery but not for arteriogenesis.
Mees B; Wagner S; Ninci E; Tribulova S; Martin S; van Haperen R; Kostin S; Heil M; de Crom R; Schaper W
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1926-33. PubMed ID: 17556651
[TBL] [Abstract][Full Text] [Related]
11. Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes.
Wilde I; Lotz S; Engelmann D; Starke A; van Zandbergen G; Solbach W; Laskay T
Med Microbiol Immunol; 2007 Jun; 196(2):61-71. PubMed ID: 17006695
[TBL] [Abstract][Full Text] [Related]
12. Locally applied macrophage-activating lipopeptide-2 (MALP-2) promotes early vascularization of implanted porous polyethylene (Medpor®).
Laschke MW; Augustin V; Kleer S; Tschernig T; Menger MD
Acta Biomater; 2014 Nov; 10(11):4661-4669. PubMed ID: 25062995
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
Takeuchi O; Kaufmann A; Grote K; Kawai T; Hoshino K; Morr M; Mühlradt PF; Akira S
J Immunol; 2000 Jan; 164(2):554-7. PubMed ID: 10623793
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-activating lipopeptide-2 downregulates the expression of ATP-binding cassette transporter A1 by activating the TLR2/NF-кB/ZNF202 pathway in THP-1 macrophages.
Peng L; Zhang Z; Zhang M; Yu X; Yao F; Tan Y; Liu D; Gong D; Chong H; Liu X; Zheng X; Tian G; Tang C
Acta Biochim Biophys Sin (Shanghai); 2016 Apr; 48(4):363-70. PubMed ID: 26922321
[TBL] [Abstract][Full Text] [Related]
15. Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis.
Sata M; Nishimatsu H; Osuga J; Tanaka K; Ishizaka N; Ishibashi S; Hirata Y; Nagai R
Hypertension; 2004 Jun; 43(6):1214-20. PubMed ID: 15166180
[TBL] [Abstract][Full Text] [Related]
16. Effects of macrophage-activating lipopeptide-2 (MALP-2) on the vascularisation of implanted polyurethane scaffolds seeded with microvascular fragments.
Grässer C; Scheuer C; Parakenings J; Tschernig T; Eglin D; Menger MD; Laschke MW
Eur Cell Mater; 2016 Jul; 32():74-86. PubMed ID: 27386841
[TBL] [Abstract][Full Text] [Related]
17. Aging-induced collateral dysfunction: impaired responsiveness of collaterals and susceptibility to apoptosis via dysfunctional eNOS signaling.
Wang J; Peng X; Lassance-Soares RM; Najafi AH; Alderman LO; Sood S; Xue Z; Chan R; Faber JE; Epstein SE; Burnett MS
J Cardiovasc Transl Res; 2011 Dec; 4(6):779-89. PubMed ID: 21538183
[TBL] [Abstract][Full Text] [Related]
18. Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2.
Sawahata R; Shime H; Yamazaki S; Inoue N; Akazawa T; Fujimoto Y; Fukase K; Matsumoto M; Seya T
Microbes Infect; 2011 Apr; 13(4):350-8. PubMed ID: 21172450
[TBL] [Abstract][Full Text] [Related]
19. Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis.
Dai X; Faber JE
Circ Res; 2010 Jun; 106(12):1870-81. PubMed ID: 20431061
[TBL] [Abstract][Full Text] [Related]
20. The TLR-2/TLR-6 agonist macrophage-activating lipopeptide-2 augments human NK cell cytotoxicity when PGE2 production by monocytes is inhibited by a COX-2 blocker.
Müller C; Tufa DM; Chatterjee D; Mühlradt PF; Schmidt RE; Jacobs R
Cancer Immunol Immunother; 2015 Sep; 64(9):1175-84. PubMed ID: 26036909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
